Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun;11(3):158-65.
doi: 10.1016/j.gpb.2013.05.003. Epub 2013 Jun 1.

Biomarker profiling for lupus nephritis

Yajuan Li  1 , Xiangdong Fang, Quan-Zhen Li
Affiliations
Review

Biomarker profiling for lupus nephritis

Yajuan Li et al. Genomics Proteomics Bioinformatics. 2013 Jun.

Abstract

Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus erythematosus (SLE), which is associated with significant morbidity and mortality of SLE patients. The pathogenesis of LN involves multiple factors, including genetic predisposition, epigenetic regulation and environmental interaction. Over the last decade, omics-based techniques have been extensively utilized for biomarker screening and a wide variety of variations which are associated with SLE and LN have been identified at the levels of genomics, transcriptomics and proteomics. These studies and discoveries have expanded our understanding of the molecular basis of the disease and are important for identification of potential therapeutic targets for disease prediction and early treatment. In this review, we summarize some of the recent studies targeted at the identification of LN-associated biomarkers using genomics and proteomic approaches.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cervera R., Abarca-Costalago M., Abramovicz D., Allegri F., Annunziata P., Aydintug A.O. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the “Euro-Lupus project”. Autoimmun Rev. 2006;5:180–186. - PubMed
    1. Gurevitz S.L., Snyder J.A., Wessel E.K., Frey J., Williamson B.A. Systemic lupus erythematosus: a review of the disease and treatment options. Consult Pharm. 2013;28:110–121. - PubMed
    1. Liu C.C., Manzi S., Ahearn J.M. Biomarkers for systemic lupus erythematosus: a review and perspective. Curr Opin Rheumatol. 2005;17:543–549. - PubMed
    1. Marchini M., Antonioli R., Lleo A., Barili M., Caronni M., Origgi L. HLA class II antigens associated with lupus nephritis in Italian SLE patients. Hum Immunol. 2003;64:462–468. - PubMed
    1. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008;40:204–210. - PMC - PubMed

Publication types